使用正统的剂量反应模型来对连续毒理学数据进行基准剂量分析
Wout Slob1, Martine I Bakker2, Bas G H Bokkers2
1Centre for Prevention, Lifestyle and Health, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Critical reviews in toxicology
|April 9, 2025
概括
我们为基准剂量 (BMD) 风险评估引入"正规"的剂量反应模型,确保一致性和可解释性. 这些模型提高了毒理风险评估的透明度和可辩护性.
科学领域:
- 毒理学和风险评估
- 生物统计学和剂量反应建模
背景情况:
- 基准剂量 (BMD) 方法对于风险评估至关重要,它利用剂量反应建模来确定与轻微反应变化相关的剂量.
- 现有的方法可能缺乏一致性和生物解释性,影响风险评估的可靠性.
研究的目的:
- 引入基于风险评估原则的持续数据剂量反应建模的概念框架.
- 定义具有生物学可解释参数和基本风险评估属性的"正规"剂量反应模型.
- 根据这些法典原则,评估EFSA和美国环保署目前的骨损伤指南.
主要方法:
- 开发一个用于剂量反应建模的概念框架.
- 对剂量反应模型的五个规范性质的定义.
- 分析现有的BMD指南 (EFSA,US-EPA) 以符合正典原则.
- 对支持正规性质3的经验证据的审查 (在log-dose尺度上的平行性).
主要成果:
- 准则模型具有四个生物学上可解释的参数和五个基本的风险评估属性 (积极性,单元独立性,并行性,可比性,内部一致性).
- 目前来自EFSA和US-EPA的BMD指南仅部分遵守正规建模原则.
- 非正典模型可能导致不一致的BMD (例如,单位依赖的结果) 并阻碍贝叶斯方法.
结论:
- 规范剂量反应模型为BMD方法提供了更透明,更一致,更可辩护的方法.
- 采用正规模型提高了风险评估的可靠性和社会防御性.
- 该框架为毒理学家和风险评估人员提供了一个关键的工具,以评估BMD方法的发展.
关键词:
这就是为什么B.M.D. BMD.在BMD软件中,使用BMD软件.准则模型的正规模型.规范参数的规范参数连续的数据连续的数据.共同变量分析剂量反应反应内部一致性 内部一致性建模的选择,选择.建模透明度 建模透明度多重效应是多重效应.平行剂量反应.在此之前的分布.相对强度因素相对强度因素相对敏感度因子的相对敏感度因子更多相关视频
相关概念视频
01:26Pharmacokinetic Models: Comparison and Selection Criterion
26
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
26
01:03Dose-Response Relationship: Overview
2.8K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
2.8K
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
33
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
33
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
58
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
58
01:20Pharmacokinetic Models: Overview
509
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
509
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
48
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
48